Cargando…

951. Weight Gain Associated With Antiretroviral Therapy

BACKGROUND: Obesity is a global public health crisis with a growing prevalence in persons with human immunodeficiency virus (PWH) population. In this study, we aimed to investigate factors associated with weight gain in the PWH population. METHODS: This was a single-centered, retrospective cohort st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Yesha, Okere, Sheila, Lustberg, Mark, Malvestutto, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776257/ http://dx.doi.org/10.1093/ofid/ofaa439.1137

Ejemplares similares

835. Improvement in Diet Attenuates Antiretroviral Therapy (ART) Associated Weight Gain in Persons with Human Immunodeficiency Virus (PWH)
por: Patel, Yesha, et al.
Publicado: (2021)

893. Evaluating Weight Gain in Treatment-naïve, HIV-infected Patients Started on Antiretroviral Therapy
por: Chaudhry, Nimra, et al.
Publicado: (2021)

318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization
por: Al-Saadi, Mahmoud, et al.
Publicado: (2021)

881. Long-term Weight Gain After Initiating Combination Antiretroviral Therapy in Treatment-naïve Asian People Living with HIV
por: Ando, Naokatsu, et al.
Publicado: (2021)

553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting
por: Nichols, Courtney, et al.
Publicado: (2021)

535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab
por: Nichols, Courtney, et al.
Publicado: (2021)

107. Impact of Switching to an Antiretroviral Regimen Containing Tenofovir Alafenamide on Weight Gain and Development of Metabolic Side Effects
por: Darnell, Julia, et al.
Publicado: (2020)

P951: CLINICAL AND LABORATORY CHARACTERISTICS, COURSE AND OUTCOME OF COVID19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA
por: Sretenovic, A., et al.
Publicado: (2022)

951 Outbreak of Mixed fungemia in a Children's Hospital in the United States
por: Al-Zubeidi, Duha, et al.
Publicado: (2014)

951 The association between COVID19 infection and umbilical artery dopplers in growth-restricted pregnancies
por: Ona, Samsiya, et al.
Publicado: (2021)

946. Risk factors and Metabolic Implications of Integrase Inhibitor Associated Weight Gain
por: Asundi, Archana, et al.
Publicado: (2020)

Fungal Planet description sheets: 951–1041
por: Crous, P.W., et al.
Publicado: (2019)

Target Studies with BNL E951 at the AGS
por: Kirk, H G, et al.
Publicado: (2001)

951. Implementation and Rapid Uptake of an Antimicrobial Stewardship Clinical Decision Support System Across 19 UPMC Hospitals
por: Ryan Bariola, J, et al.
Publicado: (2022)

1048. Weight Gain after Initiation of Anti-Retroviral Therapy in Acute HIV-1
por: Kaur, Harmanpreet, et al.
Publicado: (2020)

1594. Outcomes in Patients Receiving Long-Acting Cabotegravir-Rilpivirine in a Community, Infusion Center-Based Administration Model in Columbus, Ohio
por: Nielsen, Natalie, et al.
Publicado: (2023)

72. Massive Weight Gain in People with HIV (PWH) Starting Initial Antiretroviral Therapy (ART): Risk Factors and Predictive Ability of Early Weight Gain
por: Phupitakphol, Tanit, et al.
Publicado: (2021)

333. Weight Gain Among HIV-Infected Patients in Southern India on Treatment with Integrase Strand Transfer Inhibitor-based Antiretroviral Therapy
por: Khan, Rifa, et al.
Publicado: (2019)

P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)
por: Paiva, Bruno, et al.
Publicado: (2023)

1357. Patterns of Extragenital Gonorrhea and Chlamydia Testing at a Community-Based Academic Emergency Department in Columbus, Ohio
por: Magaña, Francisco M, et al.
Publicado: (2021)

891. Minimum Manufacturing Costs and National Prices for Weight Loss Treatments, as Potential Mitigation for Anti-Retroviral Related Weight Gain in HIV
por: Levi, Jacob, et al.
Publicado: (2021)

Tensile Deformation and Fracture Behavior of Nickel-Based Superalloy DZ951G
por: Guo, Chenhao, et al.
Publicado: (2021)

1020. Higher efavirenz mid-dose plasma concentration is associated with less weight gain among virologically suppressed people living with HIV
por: Huang, Wei-chieh, et al.
Publicado: (2020)

1022. Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
por: Ladak, Amber, et al.
Publicado: (2020)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

383. Increased Need for Antimicrobial Stewardship during a COVID-19 Outbreak in New York City
por: Policar, Maurice, et al.
Publicado: (2020)

1043. The impact of integrase strand transfer inhibitors (InSTIs) on weight gain among adults with HIV in clinical care
por: Thatipelli, Sneha, et al.
Publicado: (2020)

1049. Weight Gain in Persons Living with HIV (PLWH) Treated with Bictegravir Compared to Other Integrase Strand Transfer Inhibitors
por: Fang, Michelle, et al.
Publicado: (2020)

Draft Genome Sequence of a Rare Smut Relative, Tilletiaria anomala UBC 951
por: Toome, Merje, et al.
Publicado: (2014)

Draft Genome Assembly of Filamentous Brackish Cyanobacterium Limnoraphis robusta Strain CS-951
por: Willis, Anusuya, et al.
Publicado: (2015)

POS-951 THE EVOLVING PRACTICE OF NEPHROLOGY DURING THE COVID-19 PANDEMIC IN BRUNEI DARUSSALAM
por: LIM, C.Y., et al.
Publicado: (2022)

108. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
por: Gandhi, Rajesh, et al.
Publicado: (2020)

Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living with HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy
por: McComsey, Grace A., et al.
Publicado: (2022)

334. Weight Change Associated with Antiretroviral Therapy Switch to Integrase Strand Transfer Inhibitor-Based Regimens
por: Saber, Saghar, et al.
Publicado: (2019)

316. Use of (1-3)-β-D-Glucan Assay for Diagnosis of Candidemia in Patients Hospitalized with SARS-CoV-2 Infection
por: Malik, Yesha, et al.
Publicado: (2021)

Assessment of Aspartame (E951) Occurrence in Selected Foods and Beverages on the German Market 2000–2022
por: Schorb, Sydney, et al.
Publicado: (2023)

763. Correlates of Antiretroviral Therapy Initiation Among Newly Diagnosed Older People with HIV in Ukraine
por: Allen, Amy J, et al.
Publicado: (2020)

Hospitalization time is associated with weight gain in forensic mental health patients
por: Pedersen, A.L., et al.
Publicado: (2022)

952. Weight-Gain in Treatment Naive Newly Diagnosed HIV-Infected Persons After Initiation on Integrase Strand Inhibitor Based Treatment Regimens
por: Szep, Zsofia, et al.
Publicado: (2020)

1039. Real World Community-Based HIV Rapid Start Antiretroviral with BFTAF Versus Conventional HIV Antiretroviral Therapy Start – The RoCHaCHa Study, a Pilot Study
por: Zuppelli, Ashley R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tem0s6q0ihuk670lhp5srs22ra